Tricyclic antidepressants (amitriptyline, desipramine ) and anticonvulsants (gabapentin, carbamazepine) have demonstrated effectiveness in neuropathic cancer pain (see Research Focus box). The tricyclic antidepressants have many actions that could be involved in their pain-relieving effect and have been considered the mainstay of therapy for neuropathic pain